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ABSTRACT
The serine/threonine protein phosphatase-1 (PP1) complex is a key
regulator of the cell cycle. However, the redundancy of PP1
isoforms and the lack of specific inhibitors have hampered studies
on the global role of PP1 in cell cycle progression in vertebrates.
Here, we show that the overexpression of nuclear inhibitor of PP1
(NIPP1; also known as PPP1R8) in HeLa cells culminated in a
prometaphase arrest, associated with severe spindle-formation and
chromosome-congression defects. In addition, the spindle
assembly checkpoint was activated and checkpoint silencing was
hampered. Eventually, most cells either died by apoptosis or formed
binucleated cells. The NIPP1-induced mitotic arrest could be
explained by the inhibition of PP1 that was titrated away from
other mitotic PP1 interactors. Consistent with this notion, the mitotic-
arrest phenotype could be rescued by the overexpression of PP1 or
the inhibition of the Aurora B kinase, which acts antagonistically to
PP1. Finally, we demonstrate that the overexpression of NIPP1 also
hampered colony formation and tumor growth in xenograft assays in
a PP1-dependent manner. Our data show that the selective
inhibition of PP1 can be used to induce cancer cell death through
mitotic catastrophe.
KEY WORDS: Cell death, Mitotic catastrophe, NIPP1, Protein
phosphatase-1, Tumor growth
INTRODUCTION
Cell cycle progression is tightly controlled through reversible
phosphorylation of key regulators by a variety of protein kinases and
phosphatases (Novak et al., 2010; Qian et al., 2013a). One of the
cell-cycle-regulating enzymes is the serine/threonine protein
phosphatase-1 (PP1) a ubiquitously expressed and conserved
member of the phosphoprotein phosphatase (PPP) superfamily
(Heroes et al., 2013). PP1 forms heterodimeric or heterotrimeric
complexes with >200 PP1-interacting proteins (PIPs), which
function as substrate-targeting or -specifying subunits and activity
regulators. PP1 has established substrates in all phases of the
cell cycle, including the retinoblastoma protein in the G1 phase
(Ludlow et al., 1993), the helicase MCM4 in S-phase (Hiraga et al.,
2014), protein phosphatase Cdc25 in G2 phase (Margolis et al.,
2006) and protein kinases Aurora A and Aurora B in M-phase
(Bollen et al., 2009).
In invertebrates, the deletion of PP1 or its most abundant isoform
causes a mid-mitotic arrest that is associated with an abnormal
spindle organization and over-condensed chromosomes (Axton
et al., 1990; Chen et al., 2007; Doonan and Morris, 1989; Hisamoto
et al., 1994). In addition, the spindle assembly checkpoint (SAC),
which prevents the onset of anaphase until all chromosomes are
properly aligned and bioriented, is activated for a prolonged time
(Ohkura et al., 1989; Sassoon et al., 1999). Moreover, in those cells
where the SAC is eventually satisfied, the checkpoint cannot be
turned off in the absence of kinetochore-associated PP1 (Meadows
et al., 2011; Pinsky et al., 2009; Rosenberg et al., 2011;
Vanoosthuyse and Hardwick, 2009). It is not clear whether the
deletion or inhibition of PP1 also causes a similarly strong mitotic-
arrest phenotype in vertebrate cells. Various PIPs mediate the
interaction of PP1 with the centrosomes, spindle and mitotic
chromosomes in vertebrates, including CENP-E (Kim et al., 2010),
Kif18A (Häfner et al., 2014), KNL1 (Espert et al., 2014; Liu et al.,
2010; Nijenhuis et al., 2014), RepoMan (also known as CDCA2)
(Qian et al., 2013b; Vagnarelli et al., 2011; Wurzenberger et al.,
2012) and Sds22 (Eiteneuer et al., 2014;Wurzenberger et al., 2012).
These mitotic pools of PP1 holoenzymes have functions throughout
the M-phase. Nevertheless, the overall contribution of PP1 to cell
cycle progression in vertebrates, and cell division in particular,
remains poorly understood. The injection of inhibitory anti-PP1
antibodies into early mitotic mammalian fibroblasts has been
reported to cause a metaphase arrest (Fernandez et al., 1992), but the
effects on other stages of the cell cycle were not investigated. The
knockdown of PP1γ had no effect on the mitotic spindle but caused
a cytokinesis defect and the formation of dikaryons (Cheng et al.,
2000).
In general, it has been rather challenging to delineate the
contribution of PP1 to cell cycle progression in vertebrates, mainly
because of the lack of specific cell-permeable inhibitors. Another
problem stems from the functional redundancy between PP1
isoforms, making knockdown experiments of individual isoforms
rather uninformative (Cheng et al., 2000; Kirchner et al., 2007;
Trinkle-Mulcahy et al., 2006; Varmuza et al., 1999). We have
delineated the global role of PP1 in cell cycle progression using cell
lines that inducibly overexpress nuclear inhibitor of PP1 (NIPP1;
also known as PPP1R8). NIPP1 is a very potent and highly specific
inhibitor of PP1, and prevents the dephosphorylation of all tested
protein substrates by associated PP1, except for phosphoproteins
that are recruited through the NIPP1 N-terminal forkhead-
associated (FHA) domain (Beullens et al., 1992; Vulsteke et al.,
1997). Hence, when the phosphate-binding loop in the FHA domain
is mutated, NIPP1 can be used as a highly selective inhibitor of PP1.
Here, we show that the expression of NIPP1 causes spindle-
assembly and chromosome-congression defects, and a prolonged
SAC that often culminates in cell death. We also demonstrate that
this arrest is entirely dependent on the ability of NIPP1 to bind PP1
and is largely explained by the removal of PP1 from other mitotic
PIPs. Our data show that the global inhibition of PP1 kills dividingReceived 10 June 2015; Accepted 26 October 2015
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cancer cells and suggest that mitotic PP1 holoenzymes are potential
targets for a novel cancer therapy.
RESULTS
The overexpression of NIPP1 causes an arrest in mitosis and
cell death
To delineate the role of PP1 in cell cycle progression we generated
HeLa cell lines that inducibly express EGFP [denoted EGFP (Co)]
or fusions of EGFP with the PP1 inhibitor NIPP1, using the Flp-In
T-REx system. In addition to a fusion with wild-type NIPP1
(NIPP1-Wt), we engineered NIPP1 fusions with a non-functional
substrate-binding FHA domain (NIPP1-Fm), a mutated RVxF-type
PP1-binding site (NIPP1-Pm), and the combined mutations
(NIPP1-Fm+Pm) (Fig. 1A). The cell lines expressed the fusions
in a doxycycline (Dox)-dependent manner and to a similar extent
(Figs S1A and S2A). As expected (Tanuma et al., 2008; Van Dessel
et al., 2010), EGFP traps of the NIPP1-Wt and NIPP1-Fm fusions
showed an association with endogenous PP1, which was not
seen with the NIPP1-Pm and NIPP1-Fm+Pm fusions (Figs S1B
and S2B). The associated PP1 was inactive with glycogen
phosphorylase as substrate but the phosphatase activity could be
revealed by trypsinolysis, which destroys NIPP1 but not PP1
(Beullens et al., 1998), confirming that NIPP1-Wt and NIPP1-Fm
inhibit PP1 (Fig. S1C). In addition, the NIPP1-Wt and NIPP1-Pm
fusions co-precipitated with Sap155, a pre-mRNA splicing factor
that is an established NIPP1-FHA ligand (Fig. S1D). Such co-
precipitation was not seen with NIPP1-Fm, the FHA-ligand binding
mutant. Finally, the targeting of NIPP1 to splicing-factor storage
sites or nuclear speckles, which is also mediated by the FHA
domain (Jagiello et al., 2000), was not detected with the NIPP1-Fm
and NIPP1-Fm+Pm fusions (Figs S1E and S2C). Collectively, these
data show that EGFP–NIPP1 has the same ligand-binding
properties as endogenous NIPP1 and validate EGFP–NIPP1-Pm
and EGFP–NIPP1-Fm as PP1- and substrate-binding mutants,
respectively.
FACS analysis of non-synchronized cells revealed that the
expression of NIPP1-Wt caused an accumulation of cells with
fragmented chromatin (increased sub-G1 fraction), hinting at
increased cell death (Fig. 1B). Sulforhodamine B colorimetric
assays confirmed that there was a reduced cell survival that
depended on the concentration of ectopically expressed NIPP1-Wt
(Fig. 1C,D). To examine whether overexpressed NIPP1-Wt induced
cell death in a specific phase of the cell cycle, we performed live-cell
imaging with differential interference contrast (DIC) microscopy.
The time to mitotic entry after thymidine release amounted to 742±
36 min in non-induced and 900±42 min in NIPP1-Wt-expressing
cells (mean±s.e.m, n=30), suggesting a modest mitotic entry delay
in the induced cells (Fig. 1E). However, during this period no DNA
damagewas detected, as shown by γH2Ax stainings (Fig. S2D), and
92% of the NIPP1-Wt-expressing cells entered mitosis. Thus, the
induction of NIPP1-Wt did not have major effects on progression
through interphase and mitotic entry.
Time-lapse imaging of selected EGFP-expressing cells after the
removal of thymidine did reveal, however, a strong mitotic-arrest
phenotype after the induction of either the NIPP1-Wt or NIPP1-Fm
fusions (Fig. 2A). In these conditions few cells spent less than 2 h in
Fig. 1. The overexpression of NIPP1 causes cell death.
(A) Schematic representation of the NIPP1 fusions used for
generating stable Flp-In TREx HeLa cell lines. (B) FACS
analysis showing cell cycle distribution of asynchronous HeLa
cells before and after the induction of NIPP1-Wt expression.
Also shown is an immunoblot for the EGFP fusion in a
representative lysate. GAPDH served as a loading control.
(C) Cell survival was calculated from sulforhodamine B assays
after the induction of NIPP1-Wt expression with the indicated
Dox concentrations. Data are presented as means±s.e.m.
(n=3). **P<0.01; ***P<0.001 (Student’s t-test).
(D) Immunoblots for the EGFP fusions in representative
lysates. GAPDH served as a loading control. (E) Time until
mitosis after release from a thymidine arrest, as measured by
DIC time-lapse imaging. Data are mean±s.e.m. (n=30 cells).
**P<0.01 (Student’s t-test).
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mitosis, which was considered a normal length of mitosis. Instead,
the NIPP1-Wt- or NIPP1-Fm-expressing cells often showed a
mitotic arrest that culminated in (1) an apparently normal mitotic
exit, (2) the formation of binucleated cells, or (3) cell death (Fig. 2B,C).
Cell death was associated with membrane blebbing (Movies 1–5)
and the accumulation of caspase-3 (Fig. S1F). Importantly, cell
death did not occur when the cells were blocked in the G1/S or G2
phases of the cell cycle with thymidine or RO-3306, respectively
(data not shown), indicating that cells underwent cell death during
mitosis. In general, the mitotic-arrest phenotypes were somewhat
stronger with NIPP1-Wt- than with NIPP1-Fm-expressing cells
(Fig. 2A–C), hinting at a contribution of a functional FHA domain.
Fig. 2. The overexpression of NIPP1 causes an arrest in mitosis. (A) Duration of mitosis in non-induced or induced NIPP1-Wt and NIPP1-Fm cell lines, as
measured by DIC time-lapse imaging. The bars represent means±s.e.m. About 50 cells were analyzed for each condition. ***P<0.001; ns, not significant
(Student’s t-test). Cells were synchronized with a double thymidine block and after an 8 h release, time-lapse imaged for 60 h. (B) The fate of the stable cells in
mitosis. NM, normal mitosis (<2 h); MA, mitotic arrest (>2 h); MA+Death, mitotic arrest followed by apoptosis; MA+B,mitotic arrest leading to binucleation. The bar
diagrams show percentages of cells with the stated phenotype. (C) Same as in B but each horizontal line represents the time in mitosis of an individual cell.
(D) Immunoblotting of the indicated proteins in cell lysates. The expression of the fusion proteins (not shown for Co) was confirmed with anti-EGFP antibodies.
GAPDH served as a loading control. The mitotic phenotypes described in B–E were obtained with two independent clones of each stable cell line (data not
shown). (E) Cyclin B:GAPDH ratios for the same conditions. The data represent mean±s.e.m. (n=3). *P<0.05; **P<0.01 (Student’s t-test).
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However, the mitotic-arrest phenotype was completely absent after
the expression of NIPP1-Pm or NIPP1-Fm+Pm (Fig. 2B,C),
showing that it was entirely dependent on the ability of NIPP1 to
bind PP1. Finally, a mitotic arrest in the NIPP1-Wt- or NIPP1-Fm-
expressing cells was biochemically confirmed by immunoblotting,
showing an accumulation of the mitotic regulators cyclin B and
phosphorylated (mobility shifted) BubR1 (Fig. 2D,E).
The mitotic phenotype stems from a prometaphase arrest
and a persistently active SAC
To determine at which mitotic stage the NIPP1-Wt- or NIPP1-Fm-
expressing cells were blocked, they were followed by time-lapse
imaging after the transient expression of Cherry-tagged histone
H2B (Fig. 3A,B; Movies 6–9). This analysis revealed that ∼95% of
NIPP1-Wt- and ∼75% of NIPP1-Fm-expressing cells failed to align
their chromosomes at the metaphase plate and spent a prolonged
time in prometaphase. Some cells aligned their chromosomes at the
metaphase plate for a short period, but then regressed to a
prometaphase-like stage. Quantification of the number of cells in
prometaphase, metaphase and anaphase plus telophase after fixation
confirmed a prometaphase arrest after the induction of NIPP1-Wt or
NIPP1-Fm expression (Fig. S3).
To delineate the cause(s) of the prometaphase arrest, we first
examined spindle organization by staining fixed cells for α-tubulin
and the centrosomal marker centrobin. This revealed major spindle
defects in NIPP1-Wt- or NIPP1-Fm-expressing cells. For NIPP1-
Wt these defects included aberrant and elongated spindles with
unfocused spindle poles (Fig. 3C,D). NIPP1-Fm-expressing cells
also showed elongated spindles, but the spindle poles were focused.
In addition, a significantly longer pole-to-pole distance was
measured in NIPP1-Wt- or NIPP1-Fm-expressing cells, indicating
that there were microtubule dynamics defects (Fig. 3E). We also
often noticed chromosome-congression defects (Fig. 3C). To
quantify the latter defects, cells were first blocked in
prometaphase with monastrol, resulting in the formation of
monopolar spindles, and then allowed to progress to metaphase
by the removal of monastrol in the presence of the proteasome
inhibitor MG132. In these conditions, ∼95% of the NIPP1-Wt-
expressing cells and ∼75% of the NIPP1-Fm-expressing cells
showed chromosome misalignments, as compared to only ∼10%
without prior induction of the transgenes (Fig. 3F,G).
Problems with spindle organization or chromosome congression
are known to cause an activation of the SAC (Lesage et al., 2011).
Consistent with SAC activation, we found that NIPP1-Wt- or
NIPP1-Fm-expressing cells were enriched for hyperphosphorylated
BubR1, a SAC component (Fig. 2D). Moreover, BubR1 was
enriched at the kinetochores in these cells (Fig. 4A). In addition,
NIPP1-Wt overexpressing cells only showed a partial recovery from
a mitotic arrest following the washout of the cyclin dependent
kinase 1 (Cdk1) inhibitor R0-3306 (Fig. 4B). However, in these
experiments the mitotic index was normalized after the prior
knockdown ofMad2, an essential SAC component (Maldonado and
Kapoor, 2011), indicating that the overexpression of NIPP1-Wt
prevents the progression through mitosis because of a persistently
active SAC.
Given that PP1 contributes to SAC inactivation in yeast (London
et al., 2012; Meadows et al., 2011; Pinsky et al., 2009; Rosenberg
et al., 2011; Tang and Toda, 2015; Vanoosthuyse and Hardwick,
2009), we have also examined whether the NIPP1-Wt or NIPP1-Fm
overexpressing cells have a skewed SAC silencing. Therefore, we
performed SAC override assays (Santaguida et al., 2011) and
measured the time to complete mitosis, as detected by the loss of
cell rounding, after the inhibition of SAC activation in
prometaphase-arrested cells with the Aurora inhibitor hesperadin
or the MPS1 inhibitor reversine (Fig. 4C). With both inhibitors, the
override time was significantly increased after the expression of
either NIPP1-Wt or NIPP1-Fm, hinting at a problem with SAC
silencing.
The mitotic-arrest phenotype stems from the inhibition of
PP1
Full-length NIPP1 binds to PP1 with an extremely high affinity
and inhibits the phosphatase towards all tested protein substrates
except FHA ligands (Beullens et al., 2000; O’Connell et al., 2012;
Tanuma et al., 2008). Given that the mitotic-arrest phenotype
induced by the overexpression of NIPP1was entirely dependent on a
functional PP1-binding site, we reasoned that the phenotype could
be caused by titrating PP1 away from other PIPs. Consistent with
this notion, we found that the typical nucleolar enrichment of PP1γ
was largely lost by the induction of NIPP1-Wt or NIPP1-Fm, but not
by the expression of NIPP1-Pm (Fig. 5A). This suggests that
overexpressed NIPP1, which is itself nuclear but excluded from the
nucleoli, successfully competed with nucleolar-targeting subunit(s)
for binding to PP1. Likewise, following the expression of NIPP1-Wt
or NIPP1-Fm, considerably less PP1 activity co-precipitated with
endogenous Ki67, RepoMan and Kif18A in prometaphase-arrested
cells (Fig. 5B), indicating that NIPP1-Wt and NIPP1-Fm
competitively removed PP1 from these mitotic PIPs (Booth et al.,
2014; Häfner et al., 2014; Takagi et al., 2014; Vagnarelli et al.,
2011). This was confirmed for RepoMan by immunoblotting
(Fig. S4A). Ki67 and Kif18A are themselves substrates for
associated PP1 (Häfner et al., 2014; Takagi et al., 2014). We
noted that the expression of NIPP1-Wt or NIPP1-Fm, but not
NIPP1-Pm, reduced the mobility of Ki67 and Kif18A, during SDS-
PAGE (Fig. S4B–D), consistent with hyperphosphorylation, as
expected from their reduced association with PP1. Finally, we
observed a partial delocalization of Aurora B in mitotically arrested
cells that expressed NIPP1-Wt or NIPP1-Fm (Fig. 5C,D). Indeed, in
these cells the centromeric localization of Aurora B, which is known
to be dependent on PP1 (Qian et al., 2011), was partially lost and
showed instead a more diffuse distribution.
If the mitotic arrest induced by the overexpression of PP1-binding
NIPP1 variants is caused by the inhibition of PP1 pools that are
essential for mitosis, one would expect a (partial) rescue of this
phenotype upon the overexpression of PP1. We indeed observed
that the ectopic expression of RFP–PP1γ in the NIPP1-Fm-
expressing cell line reduced the number of cells with a mitotic
arrest (Fig. 6A; Fig. S4E). It also decreased the average duration of
mitosis (Fig. 6B), as measured by time-lapse imaging. The rescue
was proportional to the amount of expressed RFP–PP1. In addition,
when the NIPP1-Fm-expressing cells were first synchronized with
thymidine and then released for 18 h, a mitotic arrest was evident
from the accumulation of cyclin B, but this phenotype was rescued
by the expression of Flag–PP1γ (Fig. 6C,D). Finally, the SAC
inactivation defect could also be partially rescued by the expression
of RFP–PP1γ (Fig. S4F).
PP1 antagonizes the Aurora A and B kinases, both by inactivating
the kinases themselves and by dephosphorylating their substrates
(for reviews, see Bollen et al., 2009; Wurzenberger and Gerlich,
2011). Therefore, we speculated that the mitotic arrest and death
phenotype induced by the selective inhibition of PP1 should be
(partially) reversed by inhibition of the Aurora kinases. To test this
hypothesis, we made use of our observation that NIPP1-Fm reduced
cell survival, as determined by sulforhodamine B assays (Fig. 6E).
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Fig. 3. The mitotic phenotypes in NIPP1-overexpressing cells stem from a prometaphase arrest. (A) The induced stable cell lines were transiently
transfected with Cherry–histone-H2B and followed by time-lapse imaging. The figure shows representative montages (images were taken at 10-min intervals) for
mitotic control cells (Co) as well as cells expressing NIPP1-Wt or NIPP1-Fm. Themontages stop at the stagewhen cells underwent cytokinesis (Co or NIPP1-Fm)
or apoptosis (NIPP1-Wt). Scale bar: 10 μm. (B) Quantification of cells with a prolonged (pro)metaphase (>100 min). About 40 cells were analyzed by time-lapse
imaging for each condition. (C) Staining for DNA (DAPI), centrobin (Cbn) and α-tubulin in the Flp-In T-REx cell lines in the absence or presence of Dox,
showing spindle defects after the expression of NIPP1-Wt or NIPP1-Fm. Scale bar: 10 μm. (D) Quantification of the spindle defects, as illustrated in C (n=40 cells).
(E) The pole-to-pole distancewasmeasured before and after induction of NIPP1-Wt or NIPP1-Fm. Data are represented asmeans±s.e.m. (n=40 cells). **P<0.01;
***P<0.001 (Student’s t-test). (F) Non-induced and induced NIPP1-Wt- or NIPP1-Fm-expressing cells were blocked for 8 h in 100 nM monastrol
and released for 90 min in 20 μM MG132. The figure shows immunostainings for α-tubulin, a centromeric marker (Aca), and EGFP fluorescence. Scale bar:
10 μm. (G) Quantification of the observed chromosome misalignments, as illustrated in F (n=400 cells).
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As hypothesized, the reduced cell survival in cells that expressed
NIPP1-Fm was rescued by the mere addition of the Aurora inhibitor
hesperadin (Fig. 6E).
The selective inhibition of PP1 inhibits colony formation and
tumor growth
We have previously described stable HeLa Tet-off (HTO) cell lines
that express Flag-tagged NIPP1-Wt or NIPP1-Pm in the absence of
Dox (Fig. 7A) (Tanuma et al., 2008; Van Dessel et al., 2010). This
enabled us to study the effect of the selective inhibition of PP1 on
colony formation and tumor growth in the absence of an inducing
agent. Consistent with our data obtained with the Flp-In T-REx cell
lines (Fig. 2C), the expression of NIPP1-Wt in the HTO cell lines
resulted in a gradual accumulation of dead cells, but this effect was
not seen after the expression of NIPP1-Pm (Fig. 7B). The
expression of NIPP1-Wt also hampered anchorage-dependent
(Fig. 7C,D) and anchorage-independent colony formation
(Fig. 7E,F). These effects were absent in HTO cells expressing
NIPP1-Pm, demonstrating their dependency on PP1. In addition,
solid-tumor formation following the subcutaneous injection of the
HTO cells in nude mice was strongly reduced by the expression of
NIPP1-Wt, but this effect was much smaller following the
expression of NIPP1-Pm, as revealed by caliper measurements
(Fig. 7G,H) and small-animal PET scan analysis (not illustrated).
The tumor take of the control, NIPP1-Wt- and NIPP1-Pm-
expressing cells was 100%, 88% and 94%, respectively. At 30
days after injection, the average tumor size amounted to 1.13±
0.19 cm3 (Co), 0.05±0.02 cm3 (NIPP1-Wt) and 0.36±0.08 cm3
(NIPP1-Pm) (mean±s.e.m, n=16, i.e. two flanks of eight mice). It
was verified that the transgenes were expressed in the solid tumors
formed after the injection of the NIPP1-Wt (Fig. 7I) and NIPP1-Pm
(data not shown) cell lines. Moreover, the NIPP1-Wt-expressing
cells showed increased expression levels of Kif18A, NuSAP and
TPX2 (Fig. 7I,J), which have previously been shown to be
upregulated in mitotically arrested HeLa cells (Beck et al., 2011).
Thus, the selective inhibition of PP1 impairs solid-tumor growth,
which is associated with a mitotic arrest.
DISCUSSION
The main goal of this study was to delineate the contribution of PP1
to cell cycle progression in mammalian cancer cells. A knockdown
approach was not an attractive option because of the redundancy
between PP1 isoforms, which enables PIPs to form functional
complexes with other PP1 isoforms once their preferred isozyme is
removed (Gibbons et al., 2007; Kirchner et al., 2007; Trinkle-
Mulcahy et al., 2006; Varmuza et al., 1999). In addition, none of the
available small-molecule, cell-permeable inhibitors of PPP-type
phosphatases is specific for PP1, making a chemical genetics
approach unfeasible (De Munter et al., 2013; Gehringer, 2004;
Kelker et al., 2009). Therefore, we aimed to inhibit the activity of
PP1 using cell lines that inducibly express an inhibitory protein. A
similar approach has recently been successfully used to explore the
importance of PP2A for cell viability (Pores Fernando et al., 2014).
Various protein inhibitors of PP1 have been identified but most of
these are not suitable for studying global functions of PP1 in intact
cells. Indeed, some PP1 inhibitors (e.g. Inhibitor-1 and CPI-17) are
phosphorylation-dependent or only inhibit a subset of PP1
holoenzymes (Endo et al., 1996; Eto, 2009). Inhibitor-2,
Inhibitor-3 and Sds22 have been biochemically identified as
inhibitors of PP1, but genetic data from yeast indicate that they
are actually positive regulators, possibly involved in the biogenesis
of PP1 (Cheng and Chen, 2015; Eiteneuer et al., 2014; Heroes et al.,
2015). In contrast, substantial biochemical and cell biological
evidence indicates that full-length NIPP1 is a very specific and
extremely potent inhibitor of PP1 (Beullens et al., 1992, 2000;
O’Connell et al., 2012; Vulsteke et al., 1997). This applies to all
Fig. 4. The mitotic arrest induced by
the overexpression of NIPP1 is
associated with a prolonged SAC.
(A) BubR1 stainings in the indicated
cell lines, synchronized with a single
thymidine arrest and released for 18 h.
Scale bar: 10 μm. No Dox refers to the
control (Co) cell line. (B) After a control
(Ctr) or Mad2 knockdown (KD), non-
induced and induced NIPP1-Wt cells
were arrested at the G2/M transition
with RO-3306 and released for 120 or
240 min. The mitotic index
(percentage of rounded-up cells) was
derived from cell rounding and
represented asmeans±s.e.m. from two
independent experiments (n=1000
cells). ***P<0.001 (Student’s t-test).
(C) The NIPP1-Wt and NIPP1-Fm
cells, before and after induction, were
synchronized with a single thymidine
arrest, released for 5 h and then
incubated with 0.33 μM nocodazole.
After 2 h, 100 nM hesperadin (Hesp) or
500 nM reversine (Rev) was added
and the SAC override time (time to cell
flattening) was measured. Data are
means±s.e.m. (n=50 cells).
***P<0.001 (Student’s t-test).
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tested protein substrates of PP1, except for phosphoproteins that are
recruited through the FHA domain and probably represent the
natural substrates of the PP1–NIPP1 holoenzyme. Hence, NIPP1
with a non-functional FHA domain (NIPP1-Fm) can be used as a
general and specific inhibitor of PP1. Accordingly, we have found
that both NIPP1-Wt and NIPP1-Fm titrate PP1 away from other PP1
holoenzymes (Fig. 5; Fig. S4A,B,D) and that the retained PP1 is
inactive towards an exogenous PP1 substrate (Fig. S1C).
A very mild overexpression of NIPP1 in stable HeLa cell lines
(<10%), due to promoter leakage from the non-induced transgenes,
causes the expression of mesenchymal genes (Van Dessel et al.,
2015). However, this low level of overexpression had no effect on
the progression through mitosis (Fig. 2). In contrast, the induced
overexpression of NIPP1-Wt or NIPP1-Fm to levels that are several-
fold higher than that of endogenous NIPP1 caused a mitotic arrest in
a largemajority of cells. This effect was not seen with a PP1-binding
mutant of NIPP1 (NIPP1-Pm) and could be partially rescued by the
overexpression of PP1γ (Fig. 6A–D; Fig. S4E,F), which represents
strong independent evidence that this phenotype stems from the
binding and inhibition of PP1. Interestingly, the mitotic-arrest
phenotype could also be rescued by the inhibition of Aurora B
kinase (Fig. 6E), consistent with the notion that PP1 balances or
reverses signaling by Aurora kinases in mitosis, by directly
inactivating the kinases themselves and/or by dephosphorylating
their substrates (Emanuele et al., 2008; Lesage et al., 2011; Liu
et al., 2010). In general, our data demonstrate that PP1 is essential
for progression through M phase in HeLa cells, which is in
accordance with previous findings for fungi andDrosophila (Axton
et al., 1990; Chen et al., 2007; Doonan and Morris, 1989; Hisamoto
et al., 1994). It is possible that major functions of PP1 in other
phases of the cell cycle have been masked in our experiments
because NIPP1 is a nuclear protein and might not have been able to
titrate PP1 away from cytoplasmic PP1 holoenzymes that are
essential in interphase.
The prometaphase arrest that was induced by the expression of
NIPP1-Wt orNIPP1-Fmwas associatedwithmajor spindle-assembly
and chromosome-congression defects, and a prolonged SAC (Figs 3
and 4). In addition, SAC inactivation was hampered by the inhibition
of PP1. Many NIPP1-Wt- or NIPP1-Fm-expressing cells eventually
died in mitosis through apoptosis (Fig. 2B,C), also known as ‘mitotic
catastrophe’ (Castedo et al., 2004). Other cells exited mitosis and
returned to interphase without undergoing cytokinesis, a process
known as ‘slippage’ (Gascoigne and Taylor, 2008; Topham and
Taylor, 2013). Slippage occurs because the Cdk1 regulator cyclin B1
Fig. 5. Overexpression of NIPP1
disrupts PP1–PIP interactions.
(A) Localization of transiently expressed
RFP–PP1γ before and after the induction
of the indicated EGFP–NIPP1
transgenes. Scale bars: 10 μm. No Dox
refers to the NIPP1-Wt cell line.
(B) Phosphorylase phosphatase activity
in immunoprecipitates of Ki67, RepoMan
(RM) and Kif18A from STLC-arrested
cells before and after induction of the
indicated transgenes. Results are
represented as percentages of the
corresponding non-induced condition
and corrected for the amount of the
immunoprecipitated proteins. Data are
means±s.e.m. from four independent
experiments. *P<0.05; **P<0.01;
***P<0.001 (Student’s t-test). (C) Aurora
B stainings in the indicated cell lines,
synchronized with a single thymidine
arrest and nocodazole for 16 h. Aca
served as a centromere marker. Scale
bar: 10 μm. (D) Quantification of Aurora
B localization (n=50 cells).
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is slowly degraded, even when the SAC is active, which eventually
causes the Cdk1 activity to drop below the threshold level that is
needed for maintaining themitotic state. The balance betweenmitotic
catastrophe and slippage is dependent on the cell type but also shows
considerable cell-to-cell variation (Gascoigne and Taylor, 2008;
Topham and Taylor, 2013), explaining why the outcome of the
expression ofNIPP1-Wt orNIPP1-Fmwas not the same in all cells. In
any case, the severity and complexity of the observed mitotic-arrest
phenotype suggests that PP1 has multiple essential substrates in
mitosis, which agrees with the identification of multiple PIPs that
mediate the targeting of PP1 to the centrosomes, spindle and
chromosomes (Bollen et al., 2009;Wurzenberger and Gerlich, 2011).
We speculate that HeLa cell lines that inducibly express NIPP1-Fm
can be used in rescue experiments to identify the PIPs that are
important for spindle formation, microtubule dynamics, chromosome
congression and SAC silencing.
The mitotic-arrest phenotypes were generally somewhat stronger
for NIPP1-Wt than for NIPP1-Fm. Indeed, the expression of NIPP1-
Wt caused more severe chromosome congression defects, as
indicated by an increased number of misaligned chromosomes
(Fig. 3F,G). It also caused a spindle-pole focusing defect, which was
not seen after the expression of NIPP1-Fm. In addition, NIPP1-Wt-
expressing cells showed a higher incidence of mitotic catastrophe
(Fig. 2B,C). Taken together, these results hint at a contribution of
the FHA domain to the phenotype of overexpression of NIPP1-Wt.
Importantly, there was no mitotic phenotype after the expression of
NIPP1 that was mutated in both its FHA domain and RVxF-type
PP1-binding site, indicating that the contribution of the FHA
domain is PP1-dependent and cannot be explained by the mere
titration of FHA ligands from other protein complexes. Given that
NIPP1 enables the dephosphorylation of FHA ligands by associated
PP1 in a cellular context, we speculate that the stronger phenotype
associated with the expression of NIPP1-Wt is due to the
recruitment and subsequent dephosphorylation of FHA ligand(s).
It is known that at least some NIPP1 FHA ligands are
dephosphorylated at the end of mitosis (Badouel et al., 2010;
Boudrez et al., 2000, 2002; Dulla et al., 2010;Minnebo et al., 2013),
but it remains to be investigated whether the overexpression of
NIPP1 affects the dephosphorylation of its FHA ligands during
mitosis and whether this contributes to the mitotic arrest.
Finally, we have demonstrated that the overexpression of NIPP1
also hampers anchorage-dependent and -independent colony
formation and tumor growth in xenograft assays in a PP1-dependent
manner (Fig. 7). These data suggest that PP1 is a potential target for
the development of novel cancer therapies. We envisage that such
therapieswill not be based on inhibitors of the catalytic subunit,which
are likely to be toxic, unless they can be specifically targeted to cancer
cells (De Munter et al., 2013). At present there appears to be a better
therapeutic potential for molecules that interfere with the assembly or
substrate recruitment of key mitotic PP1 holoenzymes, in particular
those that are upregulated in cancer cells.
MATERIALS AND METHODS
Materials
Anti-EGFP, anti-PP1γ and sulforhodamine B were purchased from Santa
Cruz Biotechnology. Anti-α-tubulin and anti-RepoMan antibodies,
nocodazole, mineral oil and doxycycline hyclate were obtained from
Sigma-Aldrich. Anti-GAPDH and anti-cleaved caspase 3 antibodies were
purchased from Cell Signaling Technology, and anti-BubR1 and anti-
Kif18A antibodies from Bethyl laboratories. The anti-NIPP1 and anti-PP1
antibodies were made in-house, as previously described (Van Dessel et al.,
2010). Anti-Sap155, anti-cyclin B1, anti-γ-H2Ax, anti-Aurora B, anti-Aca
and anti-Flag antibodies were purchased from MBL International, BD
Pharmingen, Millipore, BD Transduction Laboratories, ImmunoVision
(Springdale, AR) and Stratagene, respectively. Anti-Ki67 and anti-centrobin
Fig. 6. The NIPP1-induced mitotic-arrest phenotype
stems from the inhibition of PP1. (A) Mitotic cell fate
under NIPP1-Fm induced and non-induced conditions, and
the transient co-expression of RFP (Co) or RFP–PP1γ. At 1
day after RFP–PP1γ transfection, the cells were arrested
with 2 mM thymidine for 24 h. Dox was added 8 h after
thymidine. Time-lapse imaging was started 8 h after the
removal of thymidine. Cell fates were defined as in
Fig. 2B,C. (B) Duration of mitosis in the same conditions.
A distinction was made between cells that expressed low
and high levels of RFP–PP1 (triangle under the graph), as
deduced from RFP color intensity. Data are presented as
mean±s.e.m. from 50 cells. *P<0.05; ***P<0.001 (Student’s
t-test). (C) NIPP1-Fm cells (with or without Dox) were
transfected for the transient expression of Flag (Co) or
Flag–PP1γ. The cells were arrested with a single thymidine
block and released for 18 h. Dox was added together with
thymidine. The figure shows immunoblots of EGFP, Cyclin
B (CyclB) and PP1γ in cell lysates. GAPDH served as a
loading control. Endo, endogenous; Exo, exogenous.
(D) Cyclin B:GAPDH ratios for the same conditions as C.
The data represent means±s.e.m. (n=4). *P<0.05
(Student’s t-test). (E) Rescue of reduced cell survival after
the expression of NIPP1-Fm by the addition of the Aurora
inhibitor hesperadin. Cell survival was calculated from
sulforhodamine B assays after the induction of NIPP1-Fm.
The cells were treated with Dox (0.5 ng/ml), in the absence
or presence of 143 nM of hesperadin. Data are presented
as means±s.e.m. (n=3). ***P<0.001 (Student’s t-test).
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antibodies were purchased from Abcam. Anti-NuSAP antibodies were
obtained from ProteinTech (Manchester, UK) and anti-TPX2 antibodies
from Novus Biologicals (Abingdon, UK). Secondary HRP-conjugated
antibodies and anti-Ki67 antibody were purchased from Dako (Heverlee,
BE) and secondary Alexa-Fluor-555- and 633-conjugated antibodies were
from Invitrogen. S-Trityl-L-Cysteine (STLC), hesperadin, thymidine,
reversine and RO-3306 were purchased from Calbiochem, Selleckchem
(Munich, Germany), Acros organics (Geel, Belgium), Cayman Chemical
and Tocris (Bristol, UK), respectively.
Cell culture and imaging
Hela Tet-off cell lines expressing Flag-tagged NIPP1 variants in the absence
of doxycycline (Dox) and Flip-In T-REx cell lines expressing EGFP or
EGFP-tagged NIPP1 variants in the presence of Dox were obtained as
described previously (Tanuma et al., 2008; Van Dessel et al., 2015).
Transfections were carried out using a commercial kit (Jet-Prime, Polyplus),
according to the manufacturer’s instructions. The used Mad2 small
interfering RNA (siRNA) has been described previously (Maldonado and
Kapoor, 2011). For immunofluorescence studies, cells grown on coverslips
Fig. 7. The selective inhibition of PP1 in
HeLa cells hampers colony formation
and tumor growth in xenograft assays.
(A) Schematic representation of the Flag-
tagged NIPP1 fusions used for generating
stable HeLa Tet-Off (HTO) cell lines. The
immunoblots underneath show the
expression of the Flag–NIPP1 fusions and
endogenous NIPP1 in the absence and
presence of Dox. Tubulin served as loading
control. (B) Cell death, as measured by
Trypan Blue stainings, after the expression
of NIPP1-Wt or NIPP1-Pm for 24–96 h. The
parental cell line was used as control (Co).
The data represents means±s.e.m. (n=3).
*P<0.05; ***P<0.001 (Student’s t-test).
(C) Anchorage-dependent growth of the cell
lines in the absence of Dox.
(D) Quantification of data from experiments
as shown in panel C. The bars represent
means±s.e.m. (n=3). *P<0.05 (Student’s
t-test). (E) Anchorage-independent
growth of the cell lines in the absence of Dox.
(F) Quantification of data from experiments
as shown in panel E. The bars represent
means±s.e.m. (n=3). *P<0.05 (Student’s
t-test). (G) The indicated HTO cells were
subcutaneously injected into both flanks of
athymic mice. Parental cells (Co) were used
as controls. The figure shows representative
pictures of the mice 4 weeks after injection.
(H) Caliper-measured tumor volumes at the
indicated times after injection of the cells.
The data represent means±s.e.m. (n=16, i.e.
two flanks of 8 mice). *P<0.05
(Student’s t-test). (I) Representative
immunoblots of tumor lysates. The blots
show the expression of Flag–NIPP1-Wt and
the mitotic markers Kif18A, NuSAP and
TPX2. GAPDH served as loading control.
(J) Quantification of data from experiments
as shown in panel I. The bars represent
means±s.e.m. (n=5–8). **P<0.01
(Student’s t-test).
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were fixed with 4% formaldehyde in Phem buffer (60 mM PIPES at pH 7,
25 mM Hepes pH 7, 10 mM EGTA and 2 mMMgCl2), permeabilized with
0.5%Triton X-100 and blocked with 3%BSA in PBS. After incubation with
primary and secondary antibodies, and DNA staining with DAPI, the
coverslips were mounted in Mowiol onto microscope slides. For some
experiments, a pre-extraction was performed. In that case, cells were
incubated before fixation for 4 min at 4°C with CSK buffer (10 mM PIPES
at pH 6.8, 300 mM sucrose, 100 mM NaCl and 3 mM MgCl2),
supplemented with 0.2% Triton X-100. Confocal images were acquired
with a Leica TCS SPE laser scanning confocal system mounted on a Leica
DMI 4000B microscope and equipped with a Leica ACS APO 40× or
63×1.30 NA oil objective.
For live-cell imaging, cells were grown in chambered coverglass four-
well plates from Thermo Scientific. For DIC imaging, cells were
synchronized with a double thymidine arrest (2 mM thymidine for 18 h,
9 h release, 2 mM thymidine for 16 h). Dox was added together with
induction of the second thymidine block. After release from this arrest the
cells were imaged for 60 h with a Leica TCS SPE laser scanning microscope
using a 20× magnification objective. Mineral oil was added to prevent
evaporation of the medium. For H2B imaging, cells were transfected with
Cherry–H2B, synchronized with a single thymidine arrest (2 mM thymidine
for 18–20 h) and after release imaged for 20 h using a 40× magnification
objective. The SAC override assay has been described previously
(Santaguida et al., 2011). The microscope was equipped with a live-
imaging chamber ensuring 37°C and 5% CO2. Images were taken every
10 min (H2B and SAC override assays) or 15 min (DIC time-lapse
imaging). Images and movies were processed with the ImageJ software
(National Institutes of Health). For quantifying the amount of RFP–PP1
overexpression (Fig. 6B), z-stack scans were performed with wide-field
microscopy (12 sections with 4-µm intervals), before live-cell imaging was
started. After processing the signals with the ImageJ software using the ‘sum
slices’ feature of z-project, a circular region with fixed diameter was
centered on randomly chosen cells and raw integrated intensities were
measured. After subtraction of the background signal, two thresholds for
PP1 expression were determined. Cells harboring RFP intensities below
350,000 were classified as ‘low overexpressing’, above that value, cells were
classified as ‘high overexpressing’.
Cell viability in HTO cells (Fig. 7B) was measured with Trypan Blue. For
this purpose, HTO cells were seeded in a 24-well plate (3500 cells/well).
After 24, 48 and 96 h, Trypan Bluewas added and the percentage of colored
cells was taken as a measure of cell death. Cell survival in Flp-In T-REx cells
(Figs 1C and 6E) was derived from sulforhodamine B colorimetric assays
(Voigt, 2005). For these experiments cells were treated with 143 nM
hesperadin or DMSO, and the indicated amounts of Dox for 48 h. After
fixation and staining with 0.4% sulforhodamine B the absorbance was
measured at 550 nm.
FACS analysis
FACS analysis was performed as described previously (Kig et al., 2013).
Briefly, asynchronous growing cells were induced or non-induced for 48 h.
After fixation in 70% ethanol, cells were stained with 50 µg/ml propidium
iodide (Sigma) and the DNA content was analyzed by cytometric analysis
(Attune Acoustic Focusing Cytometer), using the Attune FACS software.
To examine the variability of EGFP expression of the different transgenes
(Fig. S1A), cells were induced or non-induced for 24 h. Following fixation
with 70% ethanol for 10 min at room temperature, EGFP-expressing cells
were quantified with the Attune cytometer, using the Attune FACS software.
Immunoprecipitation
Immunoblotting and EGFP-trapping were performed as described
previously (Kig et al., 2013; Van Dessel et al., 2010). For the
immunoprecipitation of endogenous Ki67, RepoMan and Kif18A, cells
were first synchronized with a single thymidine arrest, released for 5 h and
incubated for 16 h with 7.5 µM S-Trityl-L-cysteine (STLC). Cells were then
lysed in RIPA lysis buffer (50 mM Tris-HCl pH 8, 150 mM NaCl, 1 mM
EDTA, 0.5% sodium deoxycholate, 1% Triton X-100 and 0.1% SDS). After
centrifugation (10 min at 3000 g), the supernatants were used for the
immunoprecipitation with the appropriate antibodies and protein-A–
Sepharose (GE Healthcare). The immunoprecipitates were washed once
with TBS complemented with 0.1 M LiCl, and three times with TBS
containing 0.1% NP-40. Afterwards, precipitates were assayed for the
presence of PP1 by measuring the glycogen phosphorylase phosphatase
activity (Beullens et al., 1992).
Colony formation and xenograft assays
For anchorage-dependent growth, 500 HTO cells were seeded in 10-cm
plates. After 2 weeks, the colonies were fixed, stained with Crystal Violet,
photographed and counted with a ColCount (Oxford Optronix, Oxford,
UK). For anchorage-independent growth, 40,000 HTO cells were first
mixed with 2 ml of culture medium containing 0.35% agarose and plated on
top of a basal layer of medium containing 0.6% agarose in a 6-well plate.
After 1 week, a fresh layer of culture medium containing 0.35% agarose was
added. After a further 2 weeks, pictures were taken.
HTO cells were cultured for 3 days in the absence of Dox. Subsequently,
3×106 cells were subcutaneously injected into both flanks of eight athymic
mice. Tumor size was measured at the indicated time points with a caliper.
Additionally, after 4 weeks the tumors of the three mice closest to the
median of each group were visualized with small animal PET (Focus 220
microPET; Concorde-CTI/Siemens) and analyzed as previously described
(Deroose et al., 2007). All animal experiments were performed according to
approved guidelines.
Statistics
The statistical significance between control and experimental groups was
calculated using paired or unpaired Student’s t-tests and is denoted as
***P<0.001; **P<0.01; *P<0.05.
Acknowledgements
We thank Annemie Hoogmartens and Fabienne Withof for providing technical
assistance.
Competing interests
The authors declare no competing or financial interests.
Author contributions
C.W., S.D.M. and N.V.D. designed and performed the experiments, and analyzed
the data. E.H. and S.B. helped with the xenograft assays. B.L. helped with the design
of experiments and live-cell imaging. M.Bo., A.V.E. andM.Be. supervised the design
and execution of the experiments, and M.Bo. coordinated the project. M.Bo. and
C.W. wrote the manuscript.
Funding
This work was supported by the Fund for Scientific Research-Flanders [grant
numbers G.0473.12, G.0482.12]; and Flemish Concerted Research Action [grant
number GOA 15/016].
Supplementary information
Supplementary information available online at
http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.175588/-/DC1
References
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